Table Info

Table 1.

Immune factors associated with endometriosis-related infertility

Auto-immune diseases, in particular

- SLE

- Celiac disease

- Inflammatory bowel disease

- Rheumatoid arthritis

- Autoimmune thyroiditis

Various autoantibodies, in particular

- ANAs

- aPLs

- Antithyroid

- Anti-endometrial

- Anti-α-enolase

- Anti-PDIK1L

- Anti-survivin

- Anti-laminin-1

- Anti-carbonic anhydrase

- Anti-GM-CSF antibodies

- Anti-syntaxin 5

- Anti-PEP

Proinflammatory factors (blood, peritoneum)

anti-PEP: anti-peptide

Declarations

Author contributions

NA, GK and AM contributed conception and design of the study; NA and AM wrote the first draft of the manuscript; KK, MC, LS, EA, GK wrote sections of the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.

Conflicts of interest

AM is an investigator of CELGENE, ROCHE, CHUGAI founded trials with APHP and Hospital 15–20 promotion; AM received several fees for congress travels and experts’ use from LFB, SANOFI, SHIRE, and CELGENE.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Bulun SE. Endometriosis. N Engl J Med. 2009;360:268–79. [DOI] [PubMed]

de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376:730–8. [DOI] [PubMed]

Zhang T, De Carolis C, Man GCW, Wang CC. The link between immunity, autoimmunity and endometriosis: a literature update. Autoimmun Rev. 2018;17:945–55. [DOI] [PubMed]

Porpora MG, Scaramuzzino S, Sangiuliano C, Piacenti I, Bonanni V, Piccioni MG, et al. High prevalence of autoimmune diseases in women with endometriosis: a case-control study. Gynecol Endocrinol. 2020;36:356–9. [DOI] [PubMed]

Shafrir AL, Palmor MC, Fourquet J, DiVasta AD, Farland LV, Vitonis AF, et al. Co-occurrence of immune-mediated conditions and endometriosis among adolescents and adult women. Am J Reprod Immunol. 2021;86:e13404. [DOI] [PubMed]

Xue YH, You LT, Ting HF, Chen YW, Sheng ZY, Xie YD, et al. Increased risk of rheumatoid arthritis among patients with endometriosis: a nationwide population-based cohort study. Rheumatology (Oxford). 2021;60:3326–33. [DOI] [PubMed]

Fan YH, Leong PY, Chiou JY, Wang YH, Ku MH, Wei JC. Association between endometriosis and risk of systemic lupus erythematosus. Sci Rep. 2021;11:532. [DOI] [PubMed] [PMC]

Lin YH, Yang YC, Chen SF, Hsu CY, Shen YC. Risk of systemic lupus erythematosus in patients with endometriosis: a nationwide population-based cohort study. Arch Gynecol Obstet. 2020;302:1197–203. [DOI] [PubMed]

Harris HR, Simard JF, Arkema EV. Endometriosis and systemic lupus erythematosus: a population-based case-control study. Lupus. 2016;25:1045–9. [DOI] [PubMed] [PMC]

10.

Harris HR, Costenbader KH, Mu F, Kvaskoff M, Malspeis S, Karlson EW, et al. Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses’ Health Study II. Ann Rheum Dis. 2016;75:1279–84. [DOI] [PubMed] [PMC]

11.

Haga HJ, Gjesdal CG, Irgens LM, Ostensen M. Reproduction and gynaecological manifestations in women with primary Sjögren’s syndrome: a case-control study. Scand J Rheumatol. 2005;34:45–8. [DOI] [PubMed]

12.

Santoro L, Campo S, D’Onofrio F, Gallo A, Covino M, Campo V, et al. Looking for celiac disease in Italian women with endometriosis: a case control study. Biomed Res Int. 2014;2014:236821. [DOI] [PubMed] [PMC]

13.

Stephansson O, Falconer H, Ludvigsson JF. Risk of endometriosis in 11,000 women with celiac disease. Hum Reprod. 2011;26:2896–901. [DOI] [PubMed]

14.

Nielsen NM, Jørgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod. 2011;26:1555–9. [DOI] [PubMed]

15.

Greenbaum H, Galper BL, Decter DH, Eisenberg VH. Endometriosis and autoimmunity: can autoantibodies be used as a non-invasive early diagnostic tool? Autoimmun Rev. 2021;20:102795. [DOI] [PubMed]

16.

Tomassetti C, Meuleman C, Pexsters A, Mihalyi A, Kyama C, Simsa P, et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online. 2006;13:58–64. [DOI] [PubMed]

17.

Fernández-Shaw S, Hicks BR, Yudkin PL, Kennedy S, Barlow DH, Starkey PM. Anti-endometrial and anti-endothelial auto-antibodies in women with endometriosis. Hum Reprod. 1993;8:310–5. [DOI] [PubMed]

18.

Taylor PV, Maloney MD, Campbell JM, Skerrow SM, Nip MM, Parmar R, et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol. 1991;98:680–4. [DOI] [PubMed]

19.

Ulcová-Gallová Z, Bouse V, Svábek L, Turek J, Rokyta Z. Endometriosis in reproductive immunology. Am J Reprod Immunol. 2002;47:269–74. [DOI] [PubMed]

20.

Caccavo D, Pellegrino NM, Totaro I, Vacca MP, Selvaggi L, Depalo R. Anti-laminin-1 antibodies in sera and follicular fluid of women with endometriosis undergoing in vitro fertilization. Int J Immunopathol Pharmacol. 2011;24:481–8. [DOI] [PubMed]

21.

Inagaki J, Hao L, Nakatsuka M, Yasuda T, Hiramatsu Y, Shoenfeld Y, et al. A possible mechanism of autoimmune-mediated infertility in women with endometriosis. Am J Reprod Immunol. 2011;66:90–9. [DOI] [PubMed]

22.

Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ, et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol. 1982;50:259–66. [PubMed] [PMC]

23.

Kaider AS, Kaider BD, Janowicz PB, Roussev RG. Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol. 1999;42:335–46. [DOI] [PubMed]

24.

Toullec L, Batteux F, Santulli P, Chouzenoux S, Jeljeli M, Belmondo T, et al. High levels of anti-GM-CSF antibodies in deep infiltrating endometriosis. Reprod Sci. 2020;27:211–7. [DOI] [PubMed]

25.

Dmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, el-Roeiy A. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril. 1995;63:555–62. [DOI] [PubMed]

26.

Nabeta M, Abe Y, Kagawa L, Haraguchi R, Kito K, Ueda N, et al. Identification of anti-α-enolase autoantibody as a novel serum marker for endometriosis. Proteomics Clin Appl. 2009;3:1201–10. [DOI] [PubMed]

27.

Lamp M, Saare M, Kadastik U, Karro H, Salumets A, Uibo R, et al. Survivin promoter polymorphisms and autoantibodies in endometriosis. J Reprod Immunol. 2012;96:95–100. [DOI] [PubMed]

28.

Nabeta M, Abe Y, Haraguchi R, Kito K, Kusanagi Y, Ito M. Serum anti-PDIK1L autoantibody as a novel marker for endometriosis. Fertil Steril. 2010;94:2552–7.e1. [DOI] [PubMed]

29.

Heitmann RJ, Tobler KJ, Gillette L, Tercero J, Burney RO. Dexamethasone attenuates the embryotoxic effect of endometriotic peritoneal fluid in a murine model. J Assist Reprod Genet. 2015;32:1317–23. [DOI] [PubMed] [PMC]

30.

Kim CH, Chae HD, Kang BM, Chang YS, Mok JE. The immunotherapy during in vitro fertilization and embryo transfer cycles in infertile patients with endometriosis. J Obstet Gynaecol Res. 1997;23:463–70. [DOI] [PubMed]

31.

Falconer H, Sundqvist J, Gemzell-Danielsson K, von Schoultz B, D’Hooghe TM, Fried G. IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reprod Biomed Online. 2009;18:582–8. [DOI] [PubMed]

32.

Barrier BF, Bates GW, Leland MM, Leach DA, Robinson RD, Propst AM. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril. 2004;81:775–9. [DOI] [PubMed]

33.

D’Antonio M, Martelli F, Peano S, Papoian R, Borrelli F. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. J Reprod Immunol. 2000;48:81–98. [DOI] [PubMed]

34.

D’Hooghe TM, Nugent NP, Cuneo S, Chai DC, Deer F, Debrock S, et al. Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biol Reprod. 2006;74:131–6. [DOI] [PubMed]

35.

Falconer H, Mwenda JM, Chai DC, Wagner C, Song XY, Mihalyi A, et al. Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Hum Reprod. 2006;21:1856–62. [DOI] [PubMed]

36.

Islimye M, Kilic S, Zulfikaroglu E, Topcu O, Zergeroglu S, Batioglu S. Regression of endometrial autografts in a rat model of endometriosis treated with etanercept. Eur J Obstet Gynecol Reprod Biol. 2011;159:184–9. [DOI] [PubMed]

37.

Koninckx PR, Craessaerts M, Timmerman D, Cornillie F, Kennedy S. Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod. 2008;23:2017–23. [DOI] [PubMed] [PMC]

38.

Önalan G, Tohma YA, Zeyneloğlu HB. Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma. Gynecol Obstet Invest. 2018;83:358–64. [DOI] [PubMed]

39.

El-Zayadi AA, Mohamed SA, Arafa M, Mohammed SM, Zayed A, Abdelhafez MS, et al. Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis. Immunol Res. 2020;68:389–97. [DOI] [PubMed]

40.

Taskin MI, Gungor AC, Adali E, Yay A, Onder GO, Inceboz U. A humanized anti-interleukin 6 receptor monoclonal antibody, tocilizumab, for the treatment of endometriosis in a rat model. Reprod Sci. 2016;23:662–9. [DOI] [PubMed]